Atrial fibrillation independently increases dementia risk by 21% in adults under the age of 70, new research indicates.
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
The 2025 Industry Outlook suggests that while organizations are continuing to experiment with AI use cases, the fervor indicated in last year's report is waning. Fewer experts are in the exploratory ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Research finds adults under 70 with atrial fibrillation have 21% higher dementia risk, with onset cases showing a dramatic 36 ...
Disrupted SWS (critical for waste clearance) and REM sleep (key for memory) may impair the glymphatic system, hindering the ...
BeiGene is scrapping ociperlimab over a disappointing phase 3 outlook two years after Novartis handed back the anti-TIGIT ...
12h
On track to announce primary endpoint result from ORIGIN 3 trial this quarter (2Q 2025)U.S. FDA BLA submission for accelerated approval planned ...
In March 2025, Coordination Pharmaceuticals Inc. announced a phase 1b/2a Study of RiMO-301 and Hypofractionated Radiotherapy With A PD-1 Inhibitor for the Treatment of Unresectable, Recurrent or ...
A five-year clinical study has revealed that spectacle lenses equipped with highly aspherical lenslets (HAL) can ...
This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback